Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Greenwich LifeSciences, Inc. GLSI
$11.10
-$0.06 (-0.54%)
На 18:03, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
146019793.00000000
-
week52high
21.50
-
week52low
6.82
-
Revenue
0
-
P/E TTM
-19
-
Beta
3.52538700
-
EPS
-0.62000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 апр 2023 г. в 15:00
Описание компании
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | 01 сент 2021 г. | |
| Aegis Capital | Buy | 27 янв 2021 г. | |
| Aegis Capital | Buy | 26 янв 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Patel Snehal | A | 2734886 | 2000 | 27 янв 2023 г. |
| Thompson Jaye | A | 256995 | 250 | 27 янв 2023 г. |
| Patel Snehal | A | 2732886 | 1500 | 20 янв 2023 г. |
| Thompson Jaye | A | 256745 | 250 | 13 янв 2023 г. |
| Patel Snehal | A | 2731386 | 1500 | 06 янв 2023 г. |
| Patel Snehal | A | 2729886 | 4000 | 29 дек 2022 г. |
| Thompson Jaye | A | 256495 | 250 | 16 дек 2022 г. |
| Patel Snehal | A | 2725886 | 1000 | 16 дек 2022 г. |
| Patel Snehal | A | 2724886 | 2000 | 09 дек 2022 г. |
| Thompson Jaye | A | 256245 | 250 | 02 дек 2022 г. |
Новостная лента
TOPS, SURG: The Top 5 Short Squeeze Stocks This Week
InvestorPlace
10 окт 2022 г. в 11:55
Source: g0d4ather / Shutterstock.com Short squeeze stocks are still popular with speculative traders and that has us going over the top ones to keep an eye on this week! Luckily, Fintel has traders covered with its Short Squeeze Leaderboard.
GLSI, APRN: The Top 5 Short Squeeze Stocks to Watch This Week
InvestorPlace
03 окт 2022 г. в 11:08
Source: g0d4ather / Shutterstock.com Investors are still interested in short squeeze stocks and we've got them covered with the ones to watch this week! Fintel is offering up a list of the short squeeze stocks to watch with its Short Squeeze Leaderboard.
NRBO, FAZE: The Top 5 Short Squeeze Stocks to Watch This Week
InvestorPlace
19 сент 2022 г. в 11:59
Source: Alextype/Shutterstock.com Traders continue to show interest in short squeeze stocks this week as they seek out likely targets to push higher. This has us checking out Fintel's Short Squeeze Leaderboard.
ATHX, PETS: The Top 5 Short Squeeze Stocks to Watch This Week
InvestorPlace
12 сент 2022 г. в 11:37
Source: g0d4ather / Shutterstock.com We're starting off another week with a deep dive into the short squeeze stocks to watch! Short squeeze stocks have been popular with traders in recent months as they search for the next big breakout.
Greenwich LifeSciences: Persevering CEO And Interesting Data
Seeking Alpha
06 сент 2022 г. в 17:40
Greenwich LifeSciences, Inc. is a one-man, one-asset shop. The asset, GP2, has produced excellent breast cancer data.